How can we track side effects to new vaccines that are used in emergency situations? And how can we create an environment where citizens feel comfortable about reporting side effects? In UMC’s podcast, doctor Rebecca Chandler talks about medicines safety in emergencies, and how pharmacovigilance fits into the One Health approach.
One Health was the lead concept behind Uppsala Health Summit’s conference “Tackling infectious disease threats: Prevent, detect, respond with a One Health approach”, held in Uppsala, Sweden, in October 2017. The post-conference report was published on February 1, 2018, and is available for download here.
During the conference, Dr Chandler hosted the workshop “New medicines and vaccines – Monitor safety in emergency situations?”. Using the H1N1 influenza pandemic of 2009-2010, and the West Africa Ebola epidemic of 2013-2016 as examples, she and her guest speakers explored the particular challenges pharmacovigilance faces when new vaccines are deployed in outbreak situations.
In the first-ever episode of UMC's podcast, we discuss why pharmacovigilance has been excluded from the One Health discourse so far, how safety surveillance practices must be adjusted to health emergencies, and how to build public trust and create a culture of side-effect reporting among health professionals and patients alike.
You can listen to the episode in the player below.
More information about Uppsala Health Summit’s past and future conferences can be found on their website www.uppsalahealthsummit.se. Anyone who wishes to follow UMC’s podcast directly can visit our channel on SoundCloud.